Mccping
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Did they give an indication on the time frame for the patent?
Kinda looks like the state wins were cooked into the pot stocks all ready.
This is a joke the ask gets down to 1,000 and then boom 13,500.
They won't let it loose!
20% that new IR firm is doing a great job!!!
How can this possibly tank 10% today? Oh ya if management did a better job informing the public they wouldn't have been able to issue themselves all the options!
What's the status of the patent?
The revenues actually increased 700k quarter over quarter when you take out the 2mil to MJNA.
960,000 trade was called an average trade that's one big block!
Did they tell you how many were converted recently
Does anyone know the patent application #
November 3, 2016 - 5:36 PM EDT
CV Sciences, Inc. Provides Details for Webcast Discussing Its CBD-Based Drug Development Program on November 10, 2016
Company to Discuss Development Efforts and Market Potential of its Proprietary Lead Drug Candidate, CVSI-007
LAS VEGAS, NV--(Marketwired - November 03, 2016) - CV Sciences, Inc. (OTCBB: CVSI) (the "Company", "CV Sciences", "our" or "we") will hold a webcast on Thursday, November 10, 2016 at 5:00PM Eastern Standard Time to discuss its drug development program and specifically its drug candidate utilizing synthetically-formulated CBD for use in treatment of smokeless tobacco addiction. Smokeless tobacco addiction is a huge unmet medical need, as there are currently no FDA-approved drugs to treat this widespread and deadly addiction. The current treatment market in the U.S. alone is estimated at greater than $2 billion.
The webcast can be accessed through the Investors section of the Company's website, cvsciences.com, or, attendees may register at https://attendee.gotowebinar.com/register/7551888241656804868.
About CV Sciences, Inc.
CV Sciences, Inc. (OTCBB: CVSI) operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD; and, a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors. CV Sciences, Inc. has primary offices and facilities in Las Vegas, Nevada and San Diego, California. Additional information is available from OTCMarkets.com or by visiting www.cvsciences.com.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.
Contact:
Robert Haag
Managing Director
IRTH Communications
CVSI@irthcommunications.com
866-976-4784
Source: Marketwired (November 3, 2016 - 5:36 PM EDT)
News by QuoteMedia
www.quotemedia.com
They really screwed this up could of sold a bunch higher to pay off convertible. Release a mediocre quarter then dilute great strategy boys.
WTF is going on how many shares are they selling?
They must be diluting
Where's Det he had this figured out?
With all they Have going why can't they get a more conventional loan?
I am actually surprised they are not buying anymore raw materials as they are suppose to announce some new products?
Handing out shares like they are Halloween candy
At $2.00 they could issue 3.5 mil in shares and raise $6 mil that type of financing is always deadly.
They believe their process is patent protected the patent inssuance must be close.
They are not buying any raw material from the 2016 crop they have plenty of materials that will reduce the cash outlay.
Sales are actually up about 700k for the quarter without the one time sale to mjna for the 2015 quarter:
Revenues and gross profit - We had sales of $4,151,180 and gross profit of $2,570,188 representing a gross profit percentage of 61.9% for the three months ended September 30, 2015 versus sales of $1,859,961 and gross profit of $1,122,419 representing a gross profit percentage of 60.3% for the three months ended September 30, 2014. The sales increase for the three months ended September 30, 2015 is primarily the result of the Company’s $2,000,000 sale of products to a single customer (MJNA), plus our continued efforts to expand distribution to multiple sales channels and thousands of customers, rather than the single distributor sales model used in 2014.
That's a surprise real early let's check out the progress!
This is nuts who buys 100 shares?
who throws up 53 k worth of shares with 15 minutes to go
How many .877 are ther?
If the patent had been issued they would have announced it.
Here it is:
Item 1.01 Entry into a Material Definitive Agreement.
On May 25, 2016 (the "Closing Date"), CV Sciences, Inc. (the "Company") entered into a Securities Purchase Agreement ("SPA") with an institutional accredited investor ("Investor") pursuant to which Investor invested $2,000,000 (the "Financing"). On the Closing Date, the Company issued to Investor a Secured Convertible Promissory Note (the "Note") in the principal amount of $2,055,000, in exchange for payment by Investor of $2,000,000. The principal sum of the Note reflects the amount invested, plus a 2.25% "Original Issue Discount" ("OID") and a $10,000 reimbursement of Investor's legal fees. Out of the proceeds from the Note, the Company paid the sum of $25,000 to its placement agent, Meyers & Associates, L.P. The Company received net proceeds of $1,975,000 in exchange for the Note.
In connection with the Financing, and in addition to the SPA and the Note, on the Closing Date, the Company and Investor entered into a Security Agreement, pursuant to which the Company granted a first priority lien and security interest in and to its inventory, accounts receivable and equipment to secure payment under the Note. The SPA, the Note and the Security Agreement are collectively referred to herein as the "Transaction Documents."
The Note matures in 13 months, and is convertible at the option of Investor at any time into shares of the Company's common stock at a conversion price equal to $0.50 per share. The Company may prepay the Note at any time by payment to Investor of 125% of the principal, interest and other amounts then due under the Note. The Company may prepay the Note notwithstanding an earlier notice of conversion from Investor, provided that in such event Investor may convert an amount not to exceed $300,000 under the Note.
Commencing on the date that is six (6) months from the issuance of the Note, Investor may redeem a portion of the Note in monthly amounts not to exceed $275,000. Provided the Company has not suffered an "Event of Default" and is in compliance with certain "Equity Conditions" (unless waived by Investor in either case), the Company may make redemption payments by the issuance of common stock in lieu of cash payments. If the Company chooses to make redemption payments in stock, the number of shares issuable shall be determined based upon a price per share equal to the lesser of $0.50 per share or 70% of the average of the three
(3) lowest closing bid prices in the previous twenty (20) trading days; provided, however, that the percentage reflected above (the "Conversion Factor") shall adjust downward if (a) the 20-day average bid price is below $0.25 per share (in which case the Conversion Factor shall be reduced by 10%), (b) the Company is not DWAC eligible (in which case the Conversion Factor shall be reduced by 5%), (c) there has occurred a "Major Default" (in which case the Conversion Factor shall be reduced by 5% for each Major Default).
Events of Default include the events set forth in Section 4.1 of the Note, and include, but are not limited to, failure to make timely payments, failure to deliver conversion shares, bankruptcy, receivership, insolvency, failure to reserve required shares for issuance upon conversion, and failure to be DWAC eligible. The Equity Conditions required for payment of redemption installments in stock are set forth in Attachment 1, Section A12 of the Note, and include, but are not limited to, maintaining eligibility under Rule 144, listing on an exchange, the timely delivery of all conversion shares, compliance with laws and no trading suspension.
Upon an Event of Default under the Note, Investor may accelerate the outstanding principal amount of all outstanding Note, plus accrued and unpaid interest, and other amounts owing through the date of acceleration. In the event of such acceleration, the interest rate on the Note shall accrue at 22% per annum or the maximum rate permitted under applicable law. Upon acceleration, the amount due will be 115% of the outstanding principal amount of the Note and accrued and unpaid interest, together with payment of all other amounts, costs, expenses and liquidated damages due under the Note.
Pursuant to the terms of the SPA and the Note, the Company is required to reserve and keep available out of its authorized and unissued shares of common stock a number of shares of common stock at least equal to three (3) times the number of shares issuable on conversion of the Note.
The foregoing summary description of the terms of the Transaction Documents may not contain all information that is of interest to the reader. For further . . .
If you are trying to trade this good luck!
The MM is walking it down on no volume
Very well put! The game was way better.
They are all starting their comeback what a joke the market is!
I have been in this one for w while and it's because the they have revs, good product pending patent and potential medical applications. One of the more solid plays out there a lot are just what if maybe plays.
The whole sector is getting a rinse this am!
Has anyone heard of any promotional material on CVSI?
Here is the reason many are getting hit:
Advanced Cannabis Solutions requested by the OTC Markets Group, Inc. to comment on recent trading and promotional activity
On October 12, 2016, OTC Markets informed the Company that it became aware of certain promotional activities concerning General Cannabis and its common stock. OTC Markets informed the company that it had received copies of promotional newsletter emails encouraging investors to purchase the Company's common stock. The Company has been informed that this promotional activity coincided with higher than average trading volume in the Company's stock. The Company was unaware of the promotional activity until informed by OTC Markets and is unaware of the full nature and content of this promotional activity, the responsible parties and the extent of the email newsletters' dissemination.
big tug a war going on with the shorts in the sector!
Who puts a 100,000 shares up on the ask of a penny stock? I have seen a few walls in the last couple of days that have come down let's see what happens tomorrow?
I think the shorts covered yesterday